Shandong Lukang Pharmaceutical Co., Ltd. Class ASSE: 600789

"Shandong Lukang Pharmaceutical Co., Ltd."Announcement on Obtaining Notice of Approval for Marketing of Chemical API for Lenvatinib Mesylate

· Issued by Shandong Lukang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Notice of Approval for Marketing of Chemical API for Lenvatinib Mesylate

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Shandong Lukang Pharmaceutical Co., Ltd. Class A

All Shandong Lukang Pharmaceutical Co., Ltd. Class A news releases